RxDoctor Payments Data

Ronald Kane, DPM

Podiatrist · Waterloo, IANPI 1013944412

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (41.1%), education and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Stryker at 41.7% of the total. Reporting peaked in 2021 at $4,444 and has fallen 83.0% since, to $757 in 2025. Among podiatrist clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,552in general payments, 2019–2025

Across 125 payments — averaging $84.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Arthrex$3K
  • Wardlow Enterprises$1K
  • Johnson & Johnson$465
  • Organogenesis Inc.$193
  • Orthofix Medical, Inc.$184
  • plus $1K from 21 others

What the payments were for

  • Travel & lodging$2,84227%
  • Food & beverage$4,33741%
  • Education$3,37332%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,552 in reported general payments places this provider in the 90th percentile of 94 podiatrist providers in Iowa.

See all podiatrist providers in Iowa

Medicare billing

Part B allowed, 2024
$115,909
Medicare patients
361
Services billed
2,525

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip42$842
Ketoconazole52$795
Ammonium Lactate30$616
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$304
Cephalexin48$253
Clotrimazole13$252
Doxycycline Monohydrate21$226
Diclofenac Sodium25$194
Methylprednisolone18$156
Gabapentin12$118
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim22$117
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$81
Meloxicam18$74
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$67
Levofloxacin14$61

Paid to pharmacies, not to this prescriber.

Other podiatrist in Waterloo

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →